ELOXX PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $6.4M | $10.2M | $24.7M |
| FY2021 | $12.0M | $22.4M | $42.3M |
| FY2022 | $8.6M | $-10.7M | $19.2M |
| FY2023 | $1.6M | $-22.6M | $1.1M |
| FY2024 | $0 | $-24.3M | $111.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $6.4M | $10.2M | $24.7M |
| FY2021 | $12.0M | $22.4M | $42.3M |
| FY2022 | $8.6M | $-10.7M | $19.2M |
| FY2023 | $1.6M | $-22.6M | $1.1M |
| FY2024 | $0 | $-24.3M | $111.0K |